Streetbeat News

Partnerships

DRIO

DarioHealth Corp. (NASDAQ:DRIO) has announced a new employer contract for its full suite of integrated health solutions, set to launch in the second half of 2023. The contract is with an educational organization based in the Midwest, and represents continued demand for integrated multi-chronic solutions in the employer market.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 12:39 pm

TWST

MyBio, an Ireland-based life science solutions provider, has announced an exclusive distribution agreement with Twist Bioscience. This partnership will extend Twist Bioscience's reach into the Irish market, leveraging MyBio's strong commercial presence and deep ties to potential customers across Ireland.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 12:36 pm

SILC

Silicom has launched a new product line focused on Edge AI and announced a partnership with Hailo. The partnership aims to leverage Hailo's AI module in Silicom's new product line.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 12:29 pm

PSNY

TSLA

Polestar Automotive Holding UK PLC (NASDAQ:PSNY) shares are trading higher by around 5% after it reported strong Q2 deliveries. The company attained the highest-ever Q2 deliveries, delivering 36% Y/Y to around 15,800 vehicles, with a growth of 73% Y/Y in June. Polestar is on track to deliver 60,000-70,000 vehicles in 2023. The company also signed an agreement with Tesla, Inc. (NASDAQ:TSLA) to adopt the new North American Charging Standard (NACS).

Portfolio Pulse from Lekha Gupta

July 06, 2023 | 12:23 pm

SKYE

Skye Bioscience, Inc. (OTCQB:SKYE) has completed the production of its cannabinoid-based drug, SBI-100, for a planned phase 2a study of glaucoma and ocular hypertension. The production was carried out by its contract manufacturer, NextPharma Oy, in Finland. The company is now working on additional logistical and preparatory steps to start the study, which is expected to begin enrollment in the third quarter.

Portfolio Pulse from Vuk Zdinjak

July 06, 2023 | 12:23 pm

AAPL

C

ERIC

HSBC

JPM

NOK

Reliance Jio Infocomm is set to sign a $1.7 billion contract with Nokia Corp to purchase 5G network equipment. The deal, backed by HSBC Holdings, JP Morgan Chase & Co, and Citigroup, Inc, is expected to be finalized this week. This follows Nokia's recent patent cross-license deal with Apple Inc and Ericsson's partnership with Jio to build a 5G standalone network in India.

Portfolio Pulse from Anusuya Lahiri

July 06, 2023 | 12:22 pm

CRBU

GENI

KZIA

Kazia Therapeutics' Paxalisib has received fast-track designation from the FDA for treatment of solid tumor brain metastases, leading to a 39% increase in KZIA's stock. Caribou Biosciences received a $25 million equity investment from Pfizer, resulting in a 22% increase in CRBU's stock. The NFL extended its strategic partnership with Genius Sports, causing a 26% increase in GENI's stock.

Portfolio Pulse from ryanfaloona@benzinga.com

July 06, 2023 | 12:18 pm

AMRC

Ameresco, Inc. (NYSE:AMRC) has secured four contracts for Battery Energy Storage System (BESS) projects with Middle River Power (MRP) at California gas power plants. The projects, which will add 379 megawatt-hours to the California grid, are designed to enhance the efficiency of MRP's natural gas power plants and support California's goal of 100% renewable energy by 2045. The work is expected to start in Summer 2023 and be completed by Q3 2024.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 12:16 pm

BKR

NEXT

Baker Hughes (NASDAQ:BKR) has been awarded a contract by Bechtel Energy Inc. to supply three Main Refrigerant Compressors (MRCs) for NextDecade's Rio Grande LNG project in Texas. The technology is capable of producing a nameplate capacity of approximately 17.61 million tonnes per annum (MTPA). This follows another recent contract awarded by Bechtel to Baker Hughes to supply two liquefaction trains for another LNG project in Texas.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 12:15 pm

MXCT

MaxCyte has signed a strategic platform license with Lyell Immunopharma, granting Lyell non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation® technology and ExPERT™ platform. In return, MaxCyte will receive licensing fees, clinical milestone payments, and sales-based payments.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 12:11 pm